循环晚期糖基化终产物与肾移植受者长期心血管死亡风险
这项前瞻性队列研究纳入555例稳定的肾移植受者,中位随访6.9年,发现循环CML和CEL水平与心血管死亡风险独立相关(HR分别为1.55和1.53),且该关联约35%由游离巯基和可溶性VCAM-1介导。
要点
- 循环CML和CEL升高与肾移植受者长期心血管死亡风险独立相关。
- 该关联部分由炎症、氧化应激和内皮功能障碍生物标志物介导。
- 检测AGEs可能有助于识别肾移植后心血管死亡高危患者。
核心结论
- 在稳定的肾移植受者中,循环AGEs水平与长期心血管死亡风险独立相关。
研究设计与样本
- 前瞻性队列研究,纳入2001至2003年间在大学附属机构招募的555例稳定肾移植受者(年龄51±12岁,56%为男性)。
主要发现
- 中位随访6.9年期间,122例受者死亡,其中52%的死因为心血管原因。
- CML与心血管死亡风险相关(HR 1.55;95%CI 1.24-1.95;P<0.001),独立于年龄、糖尿病、吸烟、BMI、eGFR和蛋白尿。
- CEL与心血管死亡风险相关(HR 1.53;95%CI 1.18-1.98;P=0.002),独立于上述混杂因素。
- 中介分析中,游离巯基和可溶性VCAM-1一致地解释了CML和CEL与心血管死亡关联的约35%。
临床怎么用
- 对于稳定肾移植受者,可考虑检测循环AGEs(CML和CEL)以辅助评估长期心血管死亡风险。
- 干预炎症、氧化应激和内皮功能障碍可能部分降低AGEs相关的心血管死亡风险。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND AND OBJECTIVES: In kidney transplant recipients, elevated circulating advanced glycation endproducts (AGEs) are the result of increased formation and decreased kidney clearance. AGEs trigger several intracellular mechanisms that ultimately yield excess cardiovascular disease. We hypothesized that, in stable kidney transplant recipients, circulating AGEs are associated with long-term risk of cardiovascular mortality, and that such a relationship is mediated by inflammatory, oxidative stress, and endothelial dysfunction biomarkers. DESIGN, SETTING, PARTICIPANTS, & MEASUREMENTS: Prospective cohort study of stable kidney transplant recipients recruited between 2001 and 2003 in a university setting. We performed multivariable-adjusted Cox regression analyses to assess the association of AGEs (i.e., Nε-[Carboxymethyl]lysine (CML) and Nε-[Carboxyethyl]lysine (CEL), measured by tandem mass spectrometry) with cardiovascular mortality. Mediation analyses were performed according to Preacher and Hayes's procedure. RESULTS: We included 555 kidney transplant recipients (age 51±12 years, 56% men). During a median follow-up of 6.9 years, 122 kidney transplant recipients died (52% deaths were due to cardiovascular causes). CML and CEL concentrations were directly associated with cardiovascular mortality (respectively, hazard ratio, 1.55; 95% confidence interval, 1.24 to 1.95; P<0.001; and hazard ratio, 1.53; 95% confidence interval 1.18 to 1.98; P=0.002), independent of age, diabetes, smoking status, body mass index, eGFR and proteinuria. Further adjustments, including cardiovascular history, did not materially change these findings. In mediation analyses, free thiol groups and soluble vascular cell adhesion molecule-1 consistently explained approximately 35% of the association of CML and CEL with cardiovascular mortality. CONCLUSIONS: In stable kidney transplant recipients, circulating levels of AGEs are independently associated with long-term risk of cardiovascular mortality. PODCAST: This article contains a podcast at https://www.asn-online.org/media/podcast/CJASN/2019_09_17_CJN00540119.mp3.
引用
- Sotomayor CG, Gomes-Neto AW, van Londen M, et al. Circulating Advanced Glycation Endproducts and Long-Term Risk of Cardiovascular Mortality in Kidney Transplant Recipients. Clin J Am Soc Nephrol. 2019. PMID: 31530552. doi:10.2215/CJN.00540119
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。